Latest filing published 21 Jun 2016 for Niagen Bioscience, Inc., €17k.
Insider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +20.4%Entry US$3.04 · Close at T+365 US$3.66
- +35.2%Entry US$2.73 · Close at T+365 US$3.69
- +11.9%Entry US$3.27 · Close at T+365 US$3.66
- +8.6%Entry US$3.15 · Close at T+365 US$3.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Troy Allen Rhonemus: trading record in brief
Troy Allen Rhonemus appears in our data through filings on Niagen Bioscience, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 22 August 2014 and the latest from 20 June 2016.
On the market, this insider has only ever bought: 5 purchases, €36k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2016, the count stands at 2 purchases and no sales.
Half of the purchases are above €7,147 and half below. Ninety days after publication, 5 purchases show a median change of +0.9%, with the price up in 60% of them. These figures describe past trades and do not predict future prices.
The newest entry dates from 21 June 2016: an open-market purchase of €17k, in Niagen Bioscience, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Troy Allen Rhonemus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$3.8070.1% of flowCommon StockSEC:0001415889-16-006286:0Canonical exit: 18 Sept 2016 (T+90)
- 2,800 shares@ US$2.8929.9% of flowCommon StockSEC:0001415889-16-006286:1Canonical exit: 18 Sept 2016 (T+90)
- 10,000 shares@ US$0.94Common StockSEC:0001415889-14-003900:0Canonical exit: 15 Mar 2015 (T+90)
- 2,500 shares@ US$1.10Common StockSEC:0001415889-14-002624:0Canonical exit: 24 Nov 2014 (T+90)
- 2,500 shares@ US$1.20Common StockSEC:0001415889-14-002612:0Canonical exit: 20 Nov 2014 (T+90)
5 of 5 declarations